Zomedica Corp. (ZOM)

Zomedica Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	142	196	160	300	130	36
Market Cap Growth	-31.08%	22.82%	-46.82%	130.90%	263.72%	-69.33%
Enterprise Value	62	108	46	107	70	35
PE Ratio	-	-5.83	-8.94	-16.34	-7.69	-1.81
PS Ratio	5.47	7.79	8.44	72.67	-	-
PB Ratio	0.61	0.82	0.60	1.11	2.55	17.07
P/FCF Ratio	-4.47	-7.18	-11.23	-20.82	-8.01	-2.26
P/OCF Ratio	-7.40	-12.28	-13.69	-21.04	-8.01	-2.29
EV/Sales Ratio	2.37	4.30	2.45	25.83	-	-
EV/EBITDA Ratio	-1.67	-3.19	-2.34	-5.22	-4.21	-1.86
EV/EBIT Ratio	-1.63	-3.12	-2.29	-5.16	-4.14	-1.78
EV/FCF Ratio	-1.95	-3.97	-3.26	-7.40	-4.31	-2.23
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.04	-
Debt / EBITDA Ratio	-0.07	-0.08	-0.09	-0.07	-0.11	-
Debt / FCF Ratio	-0.08	-0.10	-0.12	-0.10	-0.12	-
Quick Ratio	10.66	10.26	14.97	45.10	30.63	0.24
Current Ratio	11.50	11.06	15.81	46.18	31.48	0.87
Asset Turnover	0.10	0.09	0.07	0.02	0	0
Interest Coverage	-304.32	-198.82	-20225.00	-3451.50	-23102.53	-1077.86
Return on Equity (ROE)	-14.80%	-13.10%	-6.70%	-6.70%	-49.70%	-612.00%
Return on Assets (ROA)	-14.00%	-12.40%	-6.40%	-6.60%	-42.10%	-302.40%
Return on Capital (ROIC)	-19.67%	-17.82%	-8.15%	-7.94%	-31.90%	-944.21%
Earnings Yield	-25.87%	-17.15%	-11.18%	-6.12%	-13.00%	-55.32%
FCF Yield	-22.53%	-13.92%	-8.90%	-4.80%	-12.48%	-44.15%
Buyback Yield / Dilution	-	-2.45%	-162.46%	-242.85%	-13.76%
Total Shareholder Return	-	-2.45%	-162.46%	-242.85%	-13.76%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).